Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
Condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Homologous Recombination Deficiency (HRD) Intervention: Drug: Pamiparib 60 mg PO BID Sponsor: BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials